UA19871U - Diagnostic device for detecting analyte - Google Patents
Diagnostic device for detecting analyte Download PDFInfo
- Publication number
- UA19871U UA19871U UAU200512159U UAU200512159U UA19871U UA 19871 U UA19871 U UA 19871U UA U200512159 U UAU200512159 U UA U200512159U UA U200512159 U UAU200512159 U UA U200512159U UA 19871 U UA19871 U UA 19871U
- Authority
- UA
- Ukraine
- Prior art keywords
- conjugate
- test strip
- test
- sample
- strip according
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 79
- 238000012360 testing method Methods 0.000 claims abstract description 421
- 230000027455 binding Effects 0.000 claims abstract description 34
- 239000012528 membrane Substances 0.000 claims description 134
- 239000000872 buffer Substances 0.000 claims description 128
- 239000011534 wash buffer Substances 0.000 claims description 63
- 239000000427 antigen Substances 0.000 claims description 56
- 102000036639 antigens Human genes 0.000 claims description 56
- 108091007433 antigens Proteins 0.000 claims description 56
- 239000002250 absorbent Substances 0.000 claims description 40
- 230000002745 absorbent Effects 0.000 claims description 40
- 239000011230 binding agent Substances 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 29
- 235000018102 proteins Nutrition 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 20
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 18
- 210000002700 urine Anatomy 0.000 claims description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 14
- 239000002981 blocking agent Substances 0.000 claims description 13
- 239000005018 casein Substances 0.000 claims description 11
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 11
- 235000021240 caseins Nutrition 0.000 claims description 11
- 239000000020 Nitrocellulose Substances 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 229920001220 nitrocellulos Polymers 0.000 claims description 10
- 238000011144 upstream manufacturing Methods 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 9
- 210000002381 plasma Anatomy 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 9
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 8
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 8
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 6
- 208000031886 HIV Infections Diseases 0.000 claims description 5
- 241000711549 Hepacivirus C Species 0.000 claims description 5
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 5
- 241000713340 Human immunodeficiency virus 2 Species 0.000 claims description 4
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000006229 carbon black Substances 0.000 claims description 2
- 238000002405 diagnostic procedure Methods 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 108010058683 Immobilized Proteins Proteins 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 11
- 230000000007 visual effect Effects 0.000 abstract description 11
- 230000009870 specific binding Effects 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 208000006454 hepatitis Diseases 0.000 abstract description 3
- 231100000283 hepatitis Toxicity 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000035475 disorder Diseases 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 229
- 239000004033 plastic Substances 0.000 description 26
- 229920003023 plastic Polymers 0.000 description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 239000012723 sample buffer Substances 0.000 description 19
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 18
- 239000000463 material Substances 0.000 description 16
- 239000002274 desiccant Substances 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 14
- 239000003708 ampul Substances 0.000 description 11
- 102000011632 Caseins Human genes 0.000 description 10
- 108010076119 Caseins Proteins 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 9
- 229930195725 Mannitol Natural products 0.000 description 9
- 239000000594 mannitol Substances 0.000 description 9
- 235000010355 mannitol Nutrition 0.000 description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- 229940098773 bovine serum albumin Drugs 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- 229920004890 Triton X-100 Polymers 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000011152 fibreglass Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- -1 antibodies Proteins 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 208000000143 urethritis Diseases 0.000 description 6
- 239000006172 buffering agent Substances 0.000 description 5
- 238000009597 pregnancy test Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 239000003365 glass fiber Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 3
- 229960000907 methylthioninium chloride Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 230000036436 anti-hiv Effects 0.000 description 2
- 239000008366 buffered solution Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000003743 Relaxin Human genes 0.000 description 1
- 108090000103 Relaxin Proteins 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960000874 thyrotropin Drugs 0.000 description 1
- 230000001748 thyrotropin Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/828—Protein A
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/456,771 US7393697B2 (en) | 2003-06-06 | 2003-06-06 | Diagnostic test for analytes in a sample |
| PCT/US2004/008355 WO2005003732A2 (fr) | 2003-06-06 | 2004-03-19 | Essai diagnostique pour analytes dans un echantillon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA19871U true UA19871U (en) | 2007-01-15 |
Family
ID=33490234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU200512159U UA19871U (en) | 2003-06-06 | 2004-03-19 | Diagnostic device for detecting analyte |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7393697B2 (fr) |
| EP (1) | EP1658483B1 (fr) |
| JP (1) | JP4851321B2 (fr) |
| CN (1) | CN1902489B (fr) |
| AT (2) | ATE492814T1 (fr) |
| AU (2) | AU2004254558A1 (fr) |
| BR (1) | BRPI0411059B8 (fr) |
| CA (1) | CA2528108C (fr) |
| CZ (1) | CZ16422U1 (fr) |
| DE (2) | DE212004000032U1 (fr) |
| DK (1) | DK200500290U4 (fr) |
| HK (1) | HK1084183A1 (fr) |
| PT (1) | PT2005003732W (fr) |
| UA (1) | UA19871U (fr) |
| WO (1) | WO2005003732A2 (fr) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7723124B2 (en) * | 2004-02-09 | 2010-05-25 | Rapid Pathogen Screening, Inc. | Method for the rapid diagnosis of targets in human body fluids |
| GB0412949D0 (en) * | 2004-06-10 | 2004-07-14 | Inverness Medical Switzerland | Improvements in or relating to lateral flow assay devices |
| US20060019406A1 (en) * | 2004-07-23 | 2006-01-26 | Ning Wei | Lateral flow device for the detection of large pathogens |
| US7387890B2 (en) | 2004-12-16 | 2008-06-17 | Chembio Diagnostic Systems, Inc. | Immunoassay devices and use thereof |
| US8614101B2 (en) * | 2008-05-20 | 2013-12-24 | Rapid Pathogen Screening, Inc. | In situ lysis of cells in lateral flow immunoassays |
| US20090291508A1 (en) * | 2008-05-20 | 2009-11-26 | Rapid Pathogen Screening Inc. | Nanoparticles in diagnostic tests |
| US8445293B2 (en) * | 2005-02-09 | 2013-05-21 | Rapid Pathogen Screening, Inc. | Method to increase specificity and/or accuracy of lateral flow immunoassays |
| US8470608B2 (en) * | 2008-05-20 | 2013-06-25 | Rapid Pathogen Screening, Inc | Combined visual/fluorescence analyte detection test |
| US8669052B2 (en) * | 2008-06-10 | 2014-03-11 | Rapid Pathogen Screening, Inc. | Lateral flow nucleic acid detector |
| US7189522B2 (en) | 2005-03-11 | 2007-03-13 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
| WO2006098804A2 (fr) | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dispositif de dosage immunologique a double trajet |
| US7939342B2 (en) * | 2005-03-30 | 2011-05-10 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kits employing an internal calibration system |
| US20060292034A1 (en) * | 2005-06-28 | 2006-12-28 | American Bio Medica Corporation | Saliva sample testing device |
| AU2007280929B2 (en) * | 2006-07-26 | 2012-03-22 | Abbott Rapid Diagnostics International Unlimited Company | Analysis device for biological sample |
| JP2010525322A (ja) * | 2007-04-20 | 2010-07-22 | クイデル コーポレイション | 統合乾燥剤付きの分析装置 |
| US20100304471A1 (en) * | 2007-11-29 | 2010-12-02 | Jun Tao | Assay |
| JP4913025B2 (ja) * | 2007-12-07 | 2012-04-11 | 富士フイルム株式会社 | イムノクロマトグラフ方法 |
| JP4428670B2 (ja) * | 2008-03-06 | 2010-03-10 | Ｔａｎａｋａホールディングス株式会社 | 免疫学的測定法、キット及び展開溶媒 |
| US20130196310A1 (en) | 2008-05-20 | 2013-08-01 | Rapid Pathogen Screening, Inc. | Method and Device for Combined Detection of Viral and Bacterial Infections |
| US8815609B2 (en) | 2008-05-20 | 2014-08-26 | Rapid Pathogen Screening, Inc. | Multiplanar lateral flow assay with diverting zone |
| US9068981B2 (en) | 2009-12-04 | 2015-06-30 | Rapid Pathogen Screening, Inc. | Lateral flow assays with time delayed components |
| US8962260B2 (en) | 2008-05-20 | 2015-02-24 | Rapid Pathogen Screening, Inc. | Method and device for combined detection of viral and bacterial infections |
| US9797898B2 (en) | 2008-05-20 | 2017-10-24 | Rapid Pathogen Screening, Inc. | Methods and devices for using mucolytic agents including N-acetyl cysteine (NAC) |
| US8609433B2 (en) | 2009-12-04 | 2013-12-17 | Rapid Pathogen Screening, Inc. | Multiplanar lateral flow assay with sample compressor |
| CN101603967B (zh) * | 2008-06-10 | 2015-02-18 | 英科新创(厦门)科技有限公司 | 快速检测人ABO/Rh/MN血型的方法及试剂盒 |
| US20110086359A1 (en) | 2008-06-10 | 2011-04-14 | Rapid Pathogen Screening, Inc. | Lateral flow assays |
| US20100022916A1 (en) | 2008-07-24 | 2010-01-28 | Javanbakhsh Esfandiari | Method and Apparatus for Collecting and Preparing Biological Samples for Testing |
| WO2010116979A1 (fr) * | 2009-04-09 | 2010-10-14 | アークレイ株式会社 | Outil d'analyse d'echantillons, procede de fabrication d'outil d'analyse d'echantillons, et procede pour minimiser la baisse dans la permeabilite de solution d'organe de deploiement |
| CN101614739A (zh) * | 2009-07-30 | 2009-12-30 | 杭州艾力康医药科技有限公司 | 丙型肝炎病毒抗体唾液快速检测试纸条 |
| US8012770B2 (en) | 2009-07-31 | 2011-09-06 | Invisible Sentinel, Inc. | Device for detection of antigens and uses thereof |
| CA2777061C (fr) | 2009-10-09 | 2018-06-19 | Invisible Sentinel, Inc. | Dispositif de detection d'analytes et utilisations associees |
| JP4624477B1 (ja) * | 2010-02-18 | 2011-02-02 | 田中貴金属工業株式会社 | 加工食品中の豚肉検出法およびその検出キット |
| JP4686639B1 (ja) * | 2010-02-25 | 2011-05-25 | 田中貴金属工業株式会社 | 生豚肉検出法およびその検出キット |
| CN104777298B (zh) * | 2010-04-26 | 2017-10-31 | 艾博生物医药(杭州)有限公司 | 一种检测装置 |
| CN102375054A (zh) * | 2010-08-06 | 2012-03-14 | 艾博生物医药(杭州)有限公司 | 一种包括免疫试纸条的检测装置以及生产方法 |
| EP3608021A3 (fr) | 2011-01-27 | 2020-04-22 | Invisible Sentinel, Inc. | Dispositifs de détection d'analytes, dispositifs multiplex et de type comptoir pour la détection d'analytes et leurs utilisations |
| US8603835B2 (en) | 2011-02-10 | 2013-12-10 | Chembio Diagnostic Systems, Inc. | Reduced step dual path immunoassay device and method |
| JP6061843B2 (ja) | 2011-03-31 | 2017-01-18 | 積水メディカル株式会社 | 検体不添加サンプルを操作不適サンプルと判定できるイムノクロマトグラフィーに基づく検出方法及びこれに用いるテストストリップ |
| US20140106354A1 (en) | 2011-04-18 | 2014-04-17 | Garvan Institute Of Medical Research | Method of Diagnosing Cancer |
| WO2012151465A1 (fr) | 2011-05-04 | 2012-11-08 | Pop Test, Llc | Dispositif de diagnostic |
| KR101919330B1 (ko) * | 2011-06-16 | 2018-11-19 | 후지필름 가부시키가이샤 | 고감도의 면역크로마토그래프 방법 및 면역크로마토그래프용 키트 |
| JP6190395B2 (ja) | 2012-03-09 | 2017-08-30 | インビジブル・センチネル，インコーポレーテッド | 単一信号で複数被検体を検出する方法及び組成物 |
| GB201209664D0 (en) * | 2012-05-30 | 2012-07-11 | Spd Swiss Prec Diagnostics Gmbh | Assay device |
| EP2904394A4 (fr) * | 2012-10-05 | 2016-11-16 | Verax Biomedical Inc | Dosage multi-analytes |
| CN103558385A (zh) * | 2013-11-18 | 2014-02-05 | 王勇 | 人类丙肝病毒(hcv)唾液/尿液抗体胶体金检测技术及其制备方法 |
| GB201321430D0 (en) * | 2013-12-04 | 2014-01-15 | Spd Swiss Prec Diagnostics Gmbh | Assay device |
| GB201322011D0 (en) * | 2013-12-12 | 2014-01-29 | Ge Healthcare Ltd | Controlled transfer biological sample collection devices and methods of using such devices |
| WO2015134742A1 (fr) * | 2014-03-06 | 2015-09-11 | The Regents Of The University Of California | Bâtonnet diagnostique pour détection de mélamine |
| EP3578635B1 (fr) | 2014-04-02 | 2021-11-03 | Chembio Diagnostic Systems, Inc. | Immunoessai utilisant un conjugué de piégeage |
| CN104316702B (zh) * | 2014-05-30 | 2016-08-31 | 广州万孚生物技术股份有限公司 | Pct与crp定量联检层析试纸条及其制备方法 |
| EP3194624B1 (fr) | 2014-09-15 | 2022-02-16 | Garvan Institute of Medical Research | Méthodes pour le diagnostic, le pronostic et la surveillance du cancer du sein et réactifs correspondants |
| US20160116466A1 (en) | 2014-10-27 | 2016-04-28 | Chembio Diagnostic Systems, Inc. | Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses |
| CN104535768B (zh) * | 2014-11-25 | 2016-06-22 | 东莞市莞信企业管理咨询有限公司 | 一种尿微量白蛋白检测装置 |
| US10808287B2 (en) | 2015-10-23 | 2020-10-20 | Rapid Pathogen Screening, Inc. | Methods and devices for accurate diagnosis of infections |
| CN105486859B (zh) * | 2015-11-20 | 2019-03-15 | 润和生物医药科技(汕头)有限公司 | 一种新型改进免疫层析试纸条及其制备和应用 |
| CN105548494B (zh) * | 2016-01-21 | 2018-06-29 | 浙江东方基因生物制品有限公司 | 一种绿色环保型测试棒 |
| CN105548495B (zh) * | 2016-01-21 | 2018-04-10 | 浙江东方基因生物制品有限公司 | 一种准确高效的环保型检测装置 |
| US10983119B2 (en) * | 2016-01-25 | 2021-04-20 | General Electric Company | Device for rapid diagnostic tests to detect antigens with improved sensitivity |
| JP2019510208A (ja) * | 2016-01-27 | 2019-04-11 | アンダーカバー カラーズ，インク． | 液体中の標的物質を検出するためのウェアラブル装置 |
| USD825075S1 (en) | 2016-02-23 | 2018-08-07 | Flora Bioscience, Inc. | Test strip holding device |
| CN105785050A (zh) * | 2016-04-18 | 2016-07-20 | 石河子大学 | 一种利用胶体免疫金免疫渗滤法检测布鲁氏菌病的综合缓冲液 |
| CN106290829A (zh) * | 2016-07-19 | 2017-01-04 | 杭州博拓生物科技股份有限公司 | 一种四合一联合检测试纸盒及制备工艺 |
| US20190120828A1 (en) * | 2016-10-27 | 2019-04-25 | Angela Renee Crumitie | Pregnancy test and keepsake device and method of use thereof |
| CN106970219A (zh) * | 2017-04-28 | 2017-07-21 | 北京金豪制药股份有限公司 | 一种基于胶体金法检测尿液中hiv（1+2）抗体试剂 |
| CN108226492A (zh) * | 2018-01-05 | 2018-06-29 | 潍坊科瑞斯生物科技有限公司 | A群猪轮状病毒快速elisa检测试剂盒 |
| CN108761092A (zh) * | 2018-07-18 | 2018-11-06 | 长春恒晓生物科技有限责任公司 | 建立时间分辨荧光免疫层析法检测和肽素试剂盒 |
| WO2020086396A1 (fr) * | 2018-10-23 | 2020-04-30 | Boston Microfluidics, Inc. | Dispositif de collecte d'échantillon sanguin avec horodatage et échantillon environnemental simultané |
| CN110007076B (zh) * | 2019-05-13 | 2024-02-27 | 无锡博慧斯生物医药科技有限公司 | 一种全血样本检测装置及其检测方法 |
| US11618032B2 (en) | 2020-08-31 | 2023-04-04 | International Business Machines Corporation | Multiplexed testing strip device |
| US20220349905A1 (en) * | 2021-04-28 | 2022-11-03 | Richard Eng | Methods and devices for quantitatively estimating syndecan-1 |
| CN115290892B (zh) * | 2022-06-28 | 2023-04-21 | 北京美联泰科生物技术有限公司 | 一种缓冲液在脑特异性蛋白产物9.5检测试剂盒中的应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622871A (en) | 1987-04-27 | 1997-04-22 | Unilever Patent Holdings B.V. | Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents |
| SE388694B (sv) | 1975-01-27 | 1976-10-11 | Kabi Ab | Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar |
| US4703017C1 (en) | 1984-02-14 | 2001-12-04 | Becton Dickinson Co | Solid phase assay with visual readout |
| DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
| US4960691A (en) | 1986-09-29 | 1990-10-02 | Abbott Laboratories | Chromatographic test strip for determining ligands or receptors |
| US4857453A (en) | 1987-04-07 | 1989-08-15 | Syntex (U.S.A.) Inc. | Immunoassay device |
| EP1555529A3 (fr) * | 1987-04-27 | 2008-06-04 | Inverness Medical Switzerland GmbH | Dispositif et méthode d'essai immunochromatographique à liaison spécifique |
| US4855240A (en) | 1987-05-13 | 1989-08-08 | Becton Dickinson And Company | Solid phase assay employing capillary flow |
| US4962023A (en) | 1987-06-22 | 1990-10-09 | Louisiana State University, Agricultural And Mechanical College | Single incubation immuno sorbent assay method using particle labels to detect test antigen specific antibodies in presence of other antibodies |
| DE3782248T2 (de) | 1987-06-24 | 1993-03-11 | Howa Machinery Ltd | System zur steuerung der fahrbewegung einer wagenartigen bedienungsvorrichtung. |
| US4981786A (en) | 1987-09-04 | 1991-01-01 | Syntex (U.S.A.) Inc. | Multiple port assay device |
| AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
| US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
| DE69229334T2 (de) | 1991-01-11 | 1999-12-16 | Quidel Corp | Einstufiges querfluss analysenverfahren und ein darin verwendeter nichtsaugfähiger träger |
| TW213503B (fr) | 1991-05-02 | 1993-09-21 | Fujirebio Kk | |
| JPH05126832A (ja) * | 1991-10-31 | 1993-05-21 | Fujirebio Inc | 免疫分析装置及び免疫分析方法 |
| US6168956B1 (en) | 1991-05-29 | 2001-01-02 | Beckman Coulter, Inc. | Multiple component chromatographic assay device |
| JPH08262023A (ja) * | 1991-12-30 | 1996-10-11 | Fujirebio Inc | ストリップ分析装置 |
| JP2810238B2 (ja) | 1993-11-12 | 1998-10-15 | ユニパス・リミテツド | 検定装置およびその製造 |
| US5561045A (en) * | 1994-01-04 | 1996-10-01 | Intracel Corporation | Detection reagent, article, and immunoassay method |
| US5658801A (en) * | 1994-05-03 | 1997-08-19 | Spectral Diagnostics Inc. | Medical test kit |
| US6653066B1 (en) * | 1994-06-17 | 2003-11-25 | Trinity Biotech | Device and method for detecting polyvalent substances |
| JPH08136496A (ja) * | 1994-11-02 | 1996-05-31 | Taizo Uda | バイオセンサー |
| CA2167362A1 (fr) | 1995-02-10 | 1996-08-11 | Alexei Dmitri Klimov | Appareil et methode pour la realisation d'un essai de liaisonnement entre deux materiaux absorbants |
| US5753517A (en) | 1996-03-29 | 1998-05-19 | University Of British Columbia | Quantitative immunochromatographic assays |
| JP3859027B2 (ja) * | 1996-12-18 | 2006-12-20 | 日本化薬株式会社 | 乳頭分泌液中の特定物質の測定方法 |
| JP3640278B2 (ja) * | 1996-12-20 | 2005-04-20 | 日本化薬株式会社 | アッセイ装置およびそれを用いるアッセイ方法 |
| JP3283435B2 (ja) * | 1997-03-07 | 2002-05-20 | 松下電器産業株式会社 | 免疫クロマトグラフィー装置、およびその装置における試料液の保持方法 |
| JP3786231B2 (ja) * | 1997-07-31 | 2006-06-14 | 久光製薬株式会社 | 検査用デバイス |
| JP3773339B2 (ja) * | 1997-11-07 | 2006-05-10 | アボットジャパン株式会社 | 免疫分析用クロマトグラフィストリップ |
| EP0973034A1 (fr) | 1998-07-16 | 2000-01-19 | Microbe Scope AG | Immunoessais et dispositifs pour leur fonctionnement |
| WO2000007015A1 (fr) | 1998-07-29 | 2000-02-10 | Syntron Bioresearch, Inc. | Dispositif d'analyse immunologique |
| JP2000088851A (ja) * | 1998-09-10 | 2000-03-31 | Internatl Reagents Corp | 生物学的特異反応測定法及び装置 |
| GB9821526D0 (en) | 1998-10-02 | 1998-11-25 | Genosis Inc | Capture assay |
| JP4022005B2 (ja) * | 1998-10-22 | 2007-12-12 | わかもと製薬株式会社 | 簡易抗体検査方法及び検査用キット |
| WO2000042434A1 (fr) | 1999-01-09 | 2000-07-20 | Bernd Pevec | Procede et dispositif pour determiner un analyte |
| US6528323B1 (en) | 1999-06-14 | 2003-03-04 | Praxsys Biosystems, Inc. | Bidirectional lateral flow test strip and method |
| SE9904175D0 (sv) | 1999-11-18 | 1999-11-18 | Pharmacia & Upjohn Diag Ab | Assay device and use thereof |
| US6316205B1 (en) | 2000-01-28 | 2001-11-13 | Genelabs Diagnostics Pte Ltd. | Assay devices and methods of analyte detection |
| JP3680090B2 (ja) | 2000-05-25 | 2005-08-10 | 株式会社ニチレイ | 分析装置 |
| US6372516B1 (en) | 2000-09-07 | 2002-04-16 | Sun Biomedical Laboratories, Inc. | Lateral flow test device |
| US6528325B1 (en) | 2000-10-13 | 2003-03-04 | Dexall Biomedical Labs, Inc. | Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays |
| EP1350111A2 (fr) | 2001-01-03 | 2003-10-08 | Heska Corporation | Detection d'ige specifique d'allergenes |
| US6492127B2 (en) | 2001-01-23 | 2002-12-10 | Varian, Inc. | Lateral flow testing device with on-board chemical reactant |
| WO2003016902A1 (fr) * | 2001-08-20 | 2003-02-27 | Proteome Systems Intellectual Property Pty Ltd | Procede et appareil d'epreuve diagnostique |
| JP2003107090A (ja) * | 2001-09-28 | 2003-04-09 | Nitto Denko Corp | 免疫クロマトグラフ用標識複合体組成物 |
-
2003
- 2003-06-06 US US10/456,771 patent/US7393697B2/en active Active
-
2004
- 2004-03-19 AT AT04785762T patent/ATE492814T1/de not_active IP Right Cessation
- 2004-03-19 JP JP2006509248A patent/JP4851321B2/ja not_active Expired - Lifetime
- 2004-03-19 AT AT0900504U patent/AT9863U1/de not_active IP Right Cessation
- 2004-03-19 CN CN2004800157727A patent/CN1902489B/zh not_active Expired - Lifetime
- 2004-03-19 DE DE212004000032U patent/DE212004000032U1/de not_active Expired - Lifetime
- 2004-03-19 WO PCT/US2004/008355 patent/WO2005003732A2/fr active IP Right Grant
- 2004-03-19 BR BRPI0411059A patent/BRPI0411059B8/pt active IP Right Grant
- 2004-03-19 EP EP04785762A patent/EP1658483B1/fr not_active Expired - Lifetime
- 2004-03-19 CZ CZ200517219U patent/CZ16422U1/cs not_active IP Right Cessation
- 2004-03-19 CA CA2528108A patent/CA2528108C/fr not_active Expired - Lifetime
- 2004-03-19 UA UAU200512159U patent/UA19871U/uk unknown
- 2004-03-19 PT PT2004008355A patent/PT2005003732W/pt unknown
- 2004-03-19 AU AU2004254558A patent/AU2004254558A1/en not_active Abandoned
- 2004-03-19 DE DE602004030693T patent/DE602004030693D1/de not_active Expired - Lifetime
-
2005
- 2005-12-19 DK DK200500290U patent/DK200500290U4/da not_active IP Right Cessation
-
2006
- 2006-06-08 HK HK06106552.1A patent/HK1084183A1/xx not_active IP Right Cessation
-
2010
- 2010-04-22 AU AU2010201632A patent/AU2010201632A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1658483A4 (fr) | 2007-04-04 |
| DE212004000032U1 (de) | 2006-04-06 |
| CN1902489B (zh) | 2012-07-04 |
| US20040248322A1 (en) | 2004-12-09 |
| EP1658483A2 (fr) | 2006-05-24 |
| JP2007524813A (ja) | 2007-08-30 |
| BRPI0411059B8 (pt) | 2021-07-27 |
| AU2010201632A1 (en) | 2010-05-20 |
| PT2005003732W (pt) | 2007-12-13 |
| CZ16422U1 (cs) | 2006-04-10 |
| WO2005003732A3 (fr) | 2006-07-27 |
| AU2004254558A1 (en) | 2005-01-13 |
| CA2528108C (fr) | 2013-06-11 |
| EP1658483B1 (fr) | 2010-12-22 |
| DK200500290U4 (da) | 2007-04-13 |
| CA2528108A1 (fr) | 2005-01-13 |
| ATE492814T1 (de) | 2011-01-15 |
| CN1902489A (zh) | 2007-01-24 |
| JP4851321B2 (ja) | 2012-01-11 |
| BRPI0411059B1 (pt) | 2016-08-23 |
| DK200500290U1 (da) | 2006-04-28 |
| AT9863U1 (de) | 2008-04-15 |
| HK1084183A1 (en) | 2006-07-21 |
| WO2005003732A2 (fr) | 2005-01-13 |
| DE602004030693D1 (de) | 2011-02-03 |
| BRPI0411059A (pt) | 2006-08-01 |
| US7393697B2 (en) | 2008-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA19871U (en) | Diagnostic device for detecting analyte | |
| JP2948318B2 (ja) | 特異的結合アッセイ用の赤血球の分離方法 | |
| KR101337020B1 (ko) | 신속 진단용 검사 장치 | |
| CN101547641B (zh) | 侧向流检测设备 | |
| KR102209489B1 (ko) | 바이러스 및 박테리아 감염의 복합 검출을 위한 방법 및 장치 | |
| JP4846573B2 (ja) | 基準としての天然分析物を有するラテラルフローアッセイ装置および方法 | |
| US7344893B2 (en) | Immuno-gold lateral flow assay | |
| US10379121B2 (en) | Method and device for combined detection of viral and bacterial infections | |
| US8962260B2 (en) | Method and device for combined detection of viral and bacterial infections | |
| JP5276568B2 (ja) | アッセイ用デバイス | |
| JP5430995B2 (ja) | アッセイ方法およびアッセイ用デバイス | |
| JP7130045B2 (ja) | イムノクロマトグラフキットおよび結核菌の検出方法 | |
| EP3872491B1 (fr) | Échantillon de test pour une immunochromatographie | |
| JP7425883B2 (ja) | 濃縮デバイス、検体液の濃縮方法、検体液の検査方法、及び、検査キット | |
| RU58717U1 (ru) | Диагностическая испытательная полоска | |
| KR200417666Y1 (ko) | 시료 내의 분석 대상 물질을 검출하기 위한 진단 테스트스트립 | |
| US20240077478A1 (en) | System for rapid analysis of a capillary blood sample from a subject, intended for detecting the presence of at least one analyte in said capillary blood sample |